H.C Wainwright Initiates X T L Biopharmaceuticals With Buy

By: via Benzinga
Analysts at H.C Wainwright initiated coverage on X T L Biopharmaceuticals Ltd (ADR) (NASDAQ: XTLB) with a Buy rating. The target ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.